Will Profound Medical (PROF) Report Negative Earnings Next Week? What You Should Know

Core Viewpoint - Profound Medical (PROF) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The earnings report is scheduled for March 6, 2025, and is expected to show a quarterly loss of $0.30 per share, reflecting a year-over-year change of +28.6$4.2 million, representing a 109% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 7.02% higher in the last 30 days, indicating a collective reassessment by analysts [4]. - A positive Earnings ESP of +13.33% suggests that analysts have recently become more optimistic about the company's earnings prospects [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [8]. - However, the current Zacks Rank for Profound Medical is 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [11]. Historical Performance - In the last reported quarter, Profound Medical was expected to post a loss of $0.33 per share but actually reported a loss of$0.38, resulting in a surprise of -15.15% [12]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [13]. Conclusion - While the potential for an earnings beat exists, the combination of a positive Earnings ESP and a Zacks Rank of 4 suggests that Profound Medical may not be a compelling candidate for an earnings surprise [16].